Title:
HETEROCYCLE COMPOUND
Document Type and Number:
Japanese Patent JP2016065023
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a prophylactic or therapeutic agent that has an excellent Tyk2 inhibitory action and is for autoimmune disease or inflammatory disease (in particular, inflammatory skin disease) or the like (for example, systemic lupus erythematosus, inflammatory bowel disease, psoriasis, rheumatoid arthritis, Sjogren's syndrome, Behcet's disease, multiple sclerosis, atopic dermatitis, etc.) .SOLUTION: The present invention relates to 3-amino-5-(di-cyclo-propyl-methyl)-7-(4-fluoro-1-methyl-5-(morpholin-4-yl)-lH-pyrazol-3-yl)-1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-one, etc.SELECTED DRAWING: None
Inventors:
OBA YUSUKE
YOGO YOSHINORI
SASAKI YUSUKE
SHIOKAWA ZENYU
SHIBUYA AKITO
SASAKI SATOSHI
TOKUNAGA NORIHITO
OKABE ATSUTOSHI
YOGO YOSHINORI
SASAKI YUSUKE
SHIOKAWA ZENYU
SHIBUYA AKITO
SASAKI SATOSHI
TOKUNAGA NORIHITO
OKABE ATSUTOSHI
Application Number:
JP2014195799A
Publication Date:
April 28, 2016
Filing Date:
September 25, 2014
Export Citation:
Assignee:
TAKEDA CHEMICAL INDUSTRIES LTD
International Classes:
C07D471/04; A61K31/5377; A61P1/04; A61P17/00; A61P17/06; A61P19/02; A61P25/00; A61P29/00; A61P37/02; A61P37/08; A61P43/00; C07D519/00
Attorney, Agent or Firm:
Takashima Ichi
Kyoko Doi
Mitsunori Kamata
Yaeko Tamura
Murata Miyuki
Junzo Koike
Hirofumi Toma
Kyoko Doi
Mitsunori Kamata
Yaeko Tamura
Murata Miyuki
Junzo Koike
Hirofumi Toma